US Patent 9212225 Bispecific CD33 and CD3 binding proteins
Patent 9212225 was granted and assigned to Amphivena Therapeutics on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+386 characters)
Article
Patent abstract
Described herein are binding proteins that specifically bind to human CD33, and in particular to bispecific binding proteins that specifically bind to human CD33 and human CD3. Also described herein are bispecific tandem diabodies that bind to CD33 and CD33, and their uses for immunotherapy of CD33+ cancers, diseases and conditions such as acute myeloid leukemia (AML).
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09212225 Bispecific CD33 and CD3 binding proteins US Patent 9212225 Bispecific CD33 and CD3 binding proteins
Infobox
Patent Number
0921222500
Patent Number
921222500
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
092122250
Date of Patent
December 15, 2015
0Patent Application Number
146424970
Date Filed
March 9, 2015
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
092122250
Date of Patent
December 15, 2015
0Patent Application Number
146424970
Date Filed
March 9, 2015
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09212225 Bispecific CD33 and CD3 binding proteins
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09212225
Date of patent
December 15, 2015
Patent application number
14642497
Date Filed
March 9, 2015
Patent primary examiner
Find more entities like US Patent 9212225 Bispecific CD33 and CD3 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.